{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:32:19Z","timestamp":1791052339154,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2003,2,1]],"date-time":"2003-02-01T00:00:00Z","timestamp":1044057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2003,2]]},"DOI":"10.1378\/chest.123.2.344","type":"journal-article","created":{"date-parts":[[2003,6,14]],"date-time":"2003-06-14T00:09:19Z","timestamp":1055549359000},"page":"344-350","source":"Crossref","is-referenced-by-count":344,"title":["Hemodynamics and Survival in Patients With Pulmonary Arterial Hypertension Related to Systemic Sclerosis*"],"prefix":"10.1016","volume":"123","author":[{"given":"Steven M.","family":"Kawut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren B.","family":"Taichman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine L.","family":"Archer-Chicko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold I.","family":"Palevsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen E.","family":"Kimmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1378\/chest.123.2.344_bib1","series-title":"World symposium on primary pulmonary hypertension","article-title":"Executive summary from the World Symposium on Primary Pulmonary Hypertension 1998","year":"1998"},{"key":"10.1378\/chest.123.2.344_bib2","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1046\/j.1365-3083.2000.00733.x","article-title":"Fine specificity of anti-fibrillin-1 autoantibodies in primary pulmonary hypertension syndrome","volume":"51","author":"Morse","year":"2000","journal-title":"Scand J Immunol"},{"key":"10.1378\/chest.123.2.344_bib3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0889-857X(05)70335-5","article-title":"Pulmonary hypertension in systemic autoimmune disease","volume":"23","author":"Gurubhagavatula","year":"1997","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1378\/chest.123.2.344_bib4","doi-asserted-by":"crossref","first-page":"394","DOI":"10.7326\/0003-4819-86-4-394","article-title":"Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma)","volume":"86","author":"Salerni","year":"1977","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.123.2.344_bib5","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0046-8177(90)90002-M","article-title":"The pulmonary pathologic manifestations of the CREST syndrome","volume":"21","author":"Yousem","year":"1990","journal-title":"Hum Pathol"},{"key":"10.1378\/chest.123.2.344_bib6","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/art.1780290409","article-title":"Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis","volume":"29","author":"Stupi","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1378\/chest.123.2.344_bib7","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1161\/01.CIR.80.5.1198","article-title":"Histopathology of primary pulmonary hypertension: a qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry","volume":"80","author":"Pietra","year":"1989","journal-title":"Circulation"},{"key":"10.1378\/chest.123.2.344_bib8","series-title":"The pulmonary circulation: normal and abnormal","first-page":"353","article-title":"Pulmonary hypertension in collagen vascular disease","author":"Brundage","year":"1990"},{"key":"10.1378\/chest.123.2.344_bib9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0002-9343(83)91169-5","article-title":"Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis","volume":"75","author":"Ungerer","year":"1983","journal-title":"Am J Med"},{"key":"10.1378\/chest.123.2.344_bib10","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-132-6-200003210-00002","article-title":"Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease: a randomized, controlled trial","volume":"132","author":"Badesch","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.123.2.344_bib11","doi-asserted-by":"crossref","first-page":"740","DOI":"10.7326\/0003-4819-130-9-199905040-00014","article-title":"Compassionate use of continuous prostacyclin in the management of secondary pulmonary hypertension: a case series","volume":"130","author":"McLaughlin","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.123.2.344_bib12","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1378\/chest.118.4.1077","article-title":"Hemodynamic effects of epoprostenol in patients with systemic sclerosis and pulmonary hypertension","volume":"118","author":"Strange","year":"2000","journal-title":"Chest"},{"key":"10.1378\/chest.123.2.344_bib13","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension: The Primary Pulmonary Hypertension Study Group","volume":"334","author":"Barst","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.123.2.344_bib14","doi-asserted-by":"crossref","first-page":"195S","DOI":"10.1378\/chest.114.3_Supplement.195S","article-title":"Primary pulmonary hypertension associated with the use of fenfluramine derivatives","volume":"114","author":"Simonneau","year":"1998","journal-title":"Chest"},{"key":"10.1378\/chest.123.2.344_bib15","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1183\/09031936.99.13613579","article-title":"Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot study","volume":"13","author":"Humbert","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.123.2.344_bib16","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1093\/oxfordjournals.eurheartj.a015074","article-title":"Mode of death in chronic heart failure: a request and proposition for more accurate classification","volume":"17","author":"Narang","year":"1996","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.123.2.344_bib17","first-page":"187","article-title":"Regression models and life tables (with discussion)","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc"},{"key":"10.1378\/chest.123.2.344_bib18","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","article-title":"Proportional hazards tests and diagnostics based on weighted residuals","volume":"81","author":"Grambsch","year":"1994","journal-title":"Biometrika"},{"key":"10.1378\/chest.123.2.344_bib19","series-title":"Modern epidemiology","first-page":"135","article-title":"Accuracy considerations in study design","author":"Rothman","year":"1998"},{"key":"10.1378\/chest.123.2.344_bib20","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/0002-9343(78)90455-2","article-title":"Pulmonary vascular changes in scleroderma","volume":"64","author":"Young","year":"1978","journal-title":"Am J Med"},{"key":"10.1378\/chest.123.2.344_bib21","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1161\/01.CIR.89.4.1733","article-title":"Survival in primary pulmonary hypertension: validation of a prognostic equation","volume":"89","author":"Sandoval","year":"1994","journal-title":"Circulation"},{"key":"10.1378\/chest.123.2.344_bib22","series-title":"The pulmonary circulation: normal and abnormal","first-page":"451","article-title":"NIH registry on primary pulmonary hypertension: baseline characteristics of the patients enrolled","author":"Rich","year":"1990"},{"key":"10.1378\/chest.123.2.344_bib23","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00005792-198011000-00001","article-title":"Morphologic changes in the digital arteries of patients with progressive systemic sclerosis (scleroderma) and Raynaud phenomenon","volume":"59","author":"Rodnan","year":"1980","journal-title":"Medicine (Baltimore)"},{"key":"10.1378\/chest.123.2.344_bib24","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1002\/1529-0131(199912)42:12<2638::AID-ANR20>3.0.CO;2-X","article-title":"Systemic sclerosis-associated pulmonary hypertension: short- and long-term effects of epoprostenol (prostacyclin)","volume":"42","author":"Klings","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1378\/chest.123.2.344_bib25","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1161\/01.CIR.94.3.477","article-title":"Acute hemodynamic responses to inhaled nitric oxide in patients with limited scleroderma and isolated pulmonary hypertension","volume":"94","author":"Williamson","year":"1996","journal-title":"Circulation"},{"key":"10.1378\/chest.123.2.344_bib26","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/1529-0131(199803)41:3<466::AID-ART13>3.0.CO;2-O","article-title":"The acute effects of prostacyclin on pulmonary hemodynamics","volume":"41","author":"Menon","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1378\/chest.123.2.344_bib27","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/rheumatology\/40.4.453","article-title":"Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survival","volume":"40","author":"MacGregor","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1378\/chest.123.2.344_bib28","series-title":"Systemic sclerosis","first-page":"299","article-title":"Organ involvement: pulmonary","author":"Black","year":"1996"},{"key":"10.1378\/chest.123.2.344_bib29","first-page":"754","article-title":"The lung scleroderma","volume":"42","author":"Weaver","year":"1967","journal-title":"Mayo Clin Proc"},{"key":"10.1378\/chest.123.2.344_bib30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000194399","article-title":"Esophageal motility and pulmonary function in progressive systemic sclerosis","volume":"42","author":"Denis","year":"1981","journal-title":"Respiration"},{"key":"10.1378\/chest.123.2.344_bib31","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s100670050071","article-title":"Cardiac involvement in limited systemic sclerosis: non-invasive assessment in asymptomatic patients","volume":"18","author":"Handa","year":"1999","journal-title":"Clin Rheumatol"},{"key":"10.1378\/chest.123.2.344_bib32","first-page":"1395","article-title":"Nicardipine improves myocardial perfusion in systemic sclerosis","volume":"15","author":"Kahan","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1378\/chest.123.2.344_bib33","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1136\/ard.45.9.718","article-title":"Pharmacodynamic effect of dipyridamole on thallium-201 myocardial perfusion in progressive systemic sclerosis with diffuse scleroderma","volume":"45","author":"Kahan","year":"1986","journal-title":"Ann Rheum Dis"},{"key":"10.1378\/chest.123.2.344_bib34","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJM198605293142201","article-title":"Nifedipine and thallium-201 myocardial perfusion in progressive systemic sclerosis","volume":"314","author":"Kahan","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.123.2.344_bib35","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/art.1780280607","article-title":"Decreased coronary reserve in primary scleroderma myocardial disease","volume":"28","author":"Kahan","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1378\/chest.123.2.344_bib36","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1093\/rheumatology\/39.11.1269","article-title":"Clinical and laboratory features of scleroderma patients with pulmonary hypertension","volume":"39","author":"Yamane","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1378\/chest.123.2.344_bib37","first-page":"248","article-title":"Pulmonary hypertension in interstitial lung disease: relation of vascular resistance to abnormal lung structure","volume":"88","author":"Enson","year":"1975","journal-title":"Trans Assoc Am Physicians"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215324405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215324405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T20:24:03Z","timestamp":1553113443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215324405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,2]]}},"alternative-id":["S0012369215324405"],"URL":"https:\/\/doi.org\/10.1378\/chest.123.2.344","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2003,2]]}}}